Targeting a key gene before birth could someday help lead to a treatment for Down syndrome by reversing abnormal embryonic brain development and improving cognitive function after birth, according to a Rutgers-led study by researchers at Rutgers-New Brunswick and Rutgers Robert Wood Johnson Medical School.
Recent Posts
- Join NJ ACTS Workforce Development Core for an NIH Fellowship Grant Writing Workshop this Fall
- NJACTS Community Engagement Core COVID-19 Resources
- NJACTS Community Engagement Core Available Services
- Unveiling the Biomechanical Forces that Drive Scarring.
- Scientists Discover Class of Crystals With Properties That May Prove Revolutionary.
Categories
- Community (2,291)
- Covid (988)
- CTO Events (6)
- News (2,917)
- Pilots (21)